AI in the Gartner Hype CycleWhen you’re surrounded by media coverage about new technology, it can be difficult to discern what really matters. Share XAI in the Gartner Hype Cyclehttps://pharmaphorum.com/views-analysis-digital/ai-in-the-gartner-hype-cycle/
Encouraging HCPs to ‘stop and think’Healthcare professionals (HCPs) strive to give their patients the best possible care and treatment, but it’s a tough Share XEncouraging HCPs to ‘stop and think’https://pharmaphorum.com/views-and-analysis/encouraging-hcps-to-stop-and-think/
Creating a successful and productive partnershipStrategic partnerships are a vital part of the healthcare industry, allowing companies to be greater than the sum Share XCreating a successful and productive partnershiphttps://pharmaphorum.com/spotlight/future-of-generics/creating-a-successful-and-productive-partnership/
Will AI make pharma marketers obsolete?Artificial intelligence is sometimes seen as either a panacea or a destroyer – the fix for all humanity’s Share XWill AI make pharma marketers obsolete?https://pharmaphorum.com/views-analysis-digital/will-ai-make-pharma-marketers-obsolete/
Spotlight on AI in pharma marketingArtificial intelligence (AI) is everywhere, and not just in pharma – from fantasy football to customer service, we Share XSpotlight on AI in pharma marketinghttps://pharmaphorum.com/spotlight/spotlight-on-ai-in-pharma-marketing/
Understanding AI: the need-to-know terms for pharmaceutical marketersFrom retail to finance to aviation, the applications of artificial intelligence (AI) are many and diverse, with 80% Share XUnderstanding AI: the need-to-know terms for pharmaceutical marketershttps://pharmaphorum.com/spotlight/understanding-ai-the-need-to-know-terms-for-pharmaceutical-marketers/
AI and the patient journeyThough much of the focus of AI in pharma has been on how it can impact drug discovery, Share XAI and the patient journeyhttps://pharmaphorum.com/spotlight/ai-and-the-patient-journey/
The Falsified Medicines Directive – truly an opportunity for pharma?Telling the fake from the true is often a challenge, particularly in this era of ‘fake news’. But, Share XThe Falsified Medicines Directive – truly an opportunity for pharma?https://pharmaphorum.com/spotlight/future-of-generics/falsified-medicines-directive-opportunity-pharma/
ASCO 2019 round-upWith the American Society of Clinical Oncology (ASCO) conference over for another year, Richard Staines presents a round-up Share XASCO 2019 round-uphttps://pharmaphorum.com/spotlight/asco-2019-and-the-future-of-oncology/asco-2019-round-up/
